These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8410424)
1. Reserpine reconsidered: no association with serious peptic ulcer disease. Shorr RI; Ray WA; Daugherty JR; Griffin MR J Gen Intern Med; 1993 Sep; 8(9):510-2. PubMed ID: 8410424 [TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Griffin MR; Piper JM; Daugherty JR; Snowden M; Ray WA Ann Intern Med; 1991 Feb; 114(4):257-63. PubMed ID: 1987872 [TBL] [Abstract][Full Text] [Related]
3. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Piper JM; Ray WA; Daugherty JR; Griffin MR Ann Intern Med; 1991 May; 114(9):735-40. PubMed ID: 2012355 [TBL] [Abstract][Full Text] [Related]
4. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
5. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Shorr RI; Ray WA; Daugherty JR; Griffin MR Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804 [TBL] [Abstract][Full Text] [Related]
6. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease. Smalley WE; Ray WA; Daugherty JR; Griffin MR Am J Epidemiol; 1998 Aug; 148(4):350-4. PubMed ID: 9717878 [TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Smalley WE; Ray WA; Daugherty JR; Griffin MR Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721 [TBL] [Abstract][Full Text] [Related]
8. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. García Rodríguez LA; Hernández-Díaz S Am J Epidemiol; 2004 Jan; 159(1):23-31. PubMed ID: 14693656 [TBL] [Abstract][Full Text] [Related]
9. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 50 cases of drug-induced ulcerations of the stomach and duodenum]. Batko B Wiad Lek; 1967 Apr; 20(11):1047-51. PubMed ID: 6061252 [No Abstract] [Full Text] [Related]
13. Perforation and hemorrhage from duodenal ulcer during the administration of Rauwolfia serpentina: report of five cases. WEST WO Ann Intern Med; 1958 May; 48(5):1033-9. PubMed ID: 13534220 [No Abstract] [Full Text] [Related]
14. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs. Peoples JB Am Surg; 1985 Jun; 51(6):358-62. PubMed ID: 3994179 [TBL] [Abstract][Full Text] [Related]
17. Hemorrhage from duodenal ulcer during the administration of reserpine. CUMMINS AJ; WOFFORD JD N Engl J Med; 1956 Dec; 255(25):1193-4. PubMed ID: 13378640 [No Abstract] [Full Text] [Related]
18. ABSENCE OF HISTAMINE-RESERPINE ULCERS IN PYLORIC POUCHES FREE OF ACID. SMITH GV; HOWES EL Surgery; 1964 Feb; 55():262-7. PubMed ID: 14121774 [No Abstract] [Full Text] [Related]
19. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403 [TBL] [Abstract][Full Text] [Related]
20. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Patterson MK; Castellsague J; Walker AM Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]